Skip to main content
Open Access Publications from the University of California


UC San Francisco Previously Published Works bannerUCSF

Chromatin remodelling complex dosage modulates transcription factor function in heart development.

  • Author(s): Takeuchi, Jun K
  • Lou, Xin
  • Alexander, Jeffrey M
  • Sugizaki, Hiroe
  • Delgado-Olguín, Paul
  • Holloway, Alisha K
  • Mori, Alessandro D
  • Wylie, John N
  • Munson, Chantilly
  • Zhu, Yonghong
  • Zhou, Yu-Qing
  • Yeh, Ru-Fang
  • Henkelman, R Mark
  • Harvey, Richard P
  • Metzger, Daniel
  • Metzger, Daniel
  • Chambon, Pierre
  • Stainier, Didier YR
  • Pollard, Katherine S
  • Scott, Ian C
  • Bruneau, Benoit G
  • et al.

Dominant mutations in cardiac transcription factor genes cause human inherited congenital heart defects (CHDs); however, their molecular basis is not understood. Interactions between transcription factors and the Brg1/Brm-associated factor (BAF) chromatin remodelling complex suggest potential mechanisms; however, the role of BAF complexes in cardiogenesis is not known. In this study, we show that dosage of Brg1 is critical for mouse and zebrafish cardiogenesis. Disrupting the balance between Brg1 and disease-causing cardiac transcription factors, including Tbx5, Tbx20 and Nkx2-5, causes severe cardiac anomalies, revealing an essential allelic balance between Brg1 and these cardiac transcription factor genes. This suggests that the relative levels of transcription factors and BAF complexes are important for heart development, which is supported by reduced occupancy of Brg1 at cardiac gene promoters in Tbx5 haploinsufficient hearts. Our results reveal complex dosage-sensitive interdependence between transcription factors and BAF complexes, providing a potential mechanism underlying transcription factor haploinsufficiency, with implications for multigenic inheritance of CHDs.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View